CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 21 | 1 | 7 | −13 |
| Shares | 2.47M | 1 | 40.6K | −2.43M (−98.4%) |
| Value | $297.3K | $0 | $55.2K | −$242.1K (−81.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ground Swell Capital, LLC | 11,341 | $15.4K | 0.04% |
| Tower Research Capital LLC (TRC) | 5,111 | $6.95K | 0.00% |
| Barrett & Company, Inc. | 100 | $136 | 0.00% |
Sold out (16)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Jane Street Group, LLC | 419,737 | $50.5K |
| Geode Capital Management, LLC | 387,064 | $46.6K |
| Citadel Advisors LLC | 321,874 | $38.8K |
| XTX Topco Ltd | 294,919 | $35.5K |
| Connective Capital Management, LLC | 280,055 | $33.7K |
| Integrated Wealth Concepts LLC | 250,000 | $30.1K |
| Virtu Financial LLC | 162,349 | $20.0K |
| HRT Financial LP | 156,007 | $18.0K |
| Two Sigma Investments, LP | 93,077 | $11.2K |
| Goldman Sachs Group Inc | 40,329 | $4.86K |
| Synergy Investment Management, LLC | 9 | $1 |
| Wells Fargo & Company | 4 | $0 |
| Danske Bank A/S | 2 | $0 |
| Plante Moran Financial Advisors, LLC | 1 | $0 |
| Parallel Advisors, LLC | 1 | $0 |
| Dogwood Wealth Management LLC | 1 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Global Retirement Partners, LLC | 1 | $0 |